Your session is about to expire
← Back to Search
Stent
WallFlex Biliary Fully Covered Stent for Anastomotic Biliary Stricture
N/A
Waitlist Available
Led By Divyesh Sejpal, M.D.
Research Sponsored by Boston Scientific Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post stent removal
Awards & highlights
Summary
The primary objective of this study is to demonstrate effectiveness of the WallFlex Biliary RX Fully Covered Stent for anastomotic biliary strictures in post-orthotopic liver transplant (OLT) patients.
Eligible Conditions
- Anastomotic Biliary Stricture
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months post stent removal
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post stent removal
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Stricture Resolution at the Time of Stent Removal.
Secondary outcome measures
Effectiveness of Stent at 6 Months
Re-intervention Occurrence
Safety
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: WallFlex Biliary Fully Covered StentExperimental Treatment1 Intervention
All eligible patients entered into the study will be treated with a WallFlex Biliary Fully Covered Stent
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
WallFlex Biliary Fully Covered Stent
2009
N/A
~10
Find a Location
Who is running the clinical trial?
Boston Scientific CorporationLead Sponsor
737 Previous Clinical Trials
854,226 Total Patients Enrolled
Divyesh Sejpal, M.D.Principal InvestigatorIcahn School of Medicine at Mount Sinai
Share this study with friends
Copy Link
Messenger